1. Home
  2. PCRX vs EXPI Comparison

PCRX vs EXPI Comparison

Compare PCRX & EXPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

N/A

Current Price

$22.83

Market Cap

1.0B

Sector

Health Care

ML Signal

N/A

Logo eXp World Holdings Inc.

EXPI

eXp World Holdings Inc.

N/A

Current Price

$6.02

Market Cap

1.0B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
PCRX
EXPI
Founded
2006
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.0B
IPO Year
2010
2010

Fundamental Metrics

Financial Performance
Metric
PCRX
EXPI
Price
$22.83
$6.02
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
1
Target Price
$35.33
$11.50
AVG Volume (30 Days)
736.7K
985.6K
Earning Date
01-01-0001
05-27-2026
Dividend Yield
N/A
3.29%
EPS Growth
107.44
N/A
EPS
0.16
N/A
Revenue
$541,533,000.00
$500,147,681.00
Revenue This Year
$9.77
$6.93
Revenue Next Year
$9.71
$5.37
P/E Ratio
$140.38
N/A
Revenue Growth
26.04
220.39
52 Week Low
$18.80
$6.01
52 Week High
$27.99
$12.23

Technical Indicators

Market Signals
Indicator
PCRX
EXPI
Relative Strength Index (RSI) 52.95 16.13
Support Level $20.41 N/A
Resistance Level $23.82 $11.36
Average True Range (ATR) 1.01 0.30
MACD 0.02 -0.06
Stochastic Oscillator 68.81 5.64

Price Performance

Historical Comparison
PCRX
EXPI

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

About EXPI eXp World Holdings Inc.

eXp World Holdings Inc is a cloud-based residential real estate company. The company owns and operates a cloud-based real estate brokerage and a technology platform business that develops and uses immersive technologies that help businesses increase their effectiveness and reduce costs from operating in traditional brick-and-mortar office spaces. Its business categories include Real Estate Brokerage, Technology Products and Services, Title, Escrow, Settlement Services, and Mortgage Brokerage Services.

Share on Social Networks: